Ccc_R08

• Description :

  Ccc_R08 is an orally available HBV cccDNA inhibitor that reduces extracellular levels of HBV DNA, HBsAg, and HBeAg in a dose-dependent manner. ccc_R08 is investigational for use in the treatment of HBV infections. ccc_R08 has been shown to be effective in the treatment of hepatitis C virus (HCV) .

• Stability :

  ≥ 2 years

• Purity :

  >98% (HPLC)

• Weight :

  414.84

• Molecular Formula :

  C22H19ClO6

• Notes :

  Research use only, not for human use.

• Receptor :

  HBV

• CAS Number :

  2919019-72-8